| Prolonged AMPK activation increases the expression of fatty acid transporters in cardiac myocytes and perfused hearts. | |
| | |
MedLine Citation:
|
PMID: 16710744 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Recently, fatty acid transport across the plasma membrane has been shown to be a key process that contributes to the regulation of fatty acid metabolism in the heart. Since AMP kinase activation by 5-aminoimidazole-4-carboxamide-1-beta-D: -ribofuranoside (AICAR) stimulates fatty acid oxidation, as well as the expression of selected proteins involved with energy provision, we examined (a) whether AICAR induced the expression of the fatty acid transporters FABPpm and FAT/CD36 in cardiac myocytes and in perfused hearts and (b) the signaling pathway involved. Incubation of cardiac myocytes with AICAR increased the protein expression of the fatty acid transporter FABPpm after 90 min (+27%, P < 0.05) and this protein remained stably overexpressed until 180 min. Similarly, FAT/CD36 protein expression was increased after 60 min (+38%, P < 0.05) and remained overexpressed thereafter. Protein overexpression, which occurred via transcriptional mechanisms, was dependent on the AICAR concentration, with optimal induction occurring at AICAR concentrations 1-5 mM for FABPpm and at 2-8 mM for FAT/CD36. The AICAR (2 h, 2 mM AICAR) effects on FABPpm and FAT/CD36 protein expression were similar in perfused hearts and in cardiac myocytes. AICAR also induced the plasmalemmal content of FAT/CD36 (+49%) and FABPpm (+42%) (P < 0.05). This was accompanied by a marked increase in the rate of palmitate transport (2.5 fold) into giant sarcolemmal vesicles, as well as by increased rates of palmitate oxidation in cardiac myocytes. When the AICAR-induced AMPK phosphorylation was blocked, neither FAT/CD36 nor FABPpm were overexpressed, nor were palmitate uptake and oxidation increased. This study has revealed that AMPK activation stimulates the protein expression of both fatty acid transporters, FAT/CD36 and FABPpm in (a) time- and (b) dose-dependent manner via (c) the AMPK signaling pathway. AICAR also (d) increased the plasmalemmal content of FAT/CD36 and FABPm, thereby (e) increasing the rates of fatty acid transport. Thus, activation of AMPK is a key mechanism regulating the expression as well as the plasmalemmal localization of fatty acid transporters. |
| | |
Authors:
|
Adrian Chabowski; Iman Momken; Susan L M Coort; Jorge Calles-Escandon; Narendra N Tandon; Jan F C Glatz; Joost J F P Luiken; Arend Bonen |
Related Documents
:
|
12479584 - Regulation of fatty acid transport and membrane transporters in health and disease. 5259774 - Na plus-facilitated reactions of neutral amino acids with a cationic amino acid transpo... 16126914 - Serotonin, l-tryptophan, and tryptamine are effective inhibitors of the amino acid tran... 7060564 - Picrate as an inhibitor of photosystem ii in photosynthetic electron transport. 746344 - Phosphatidylcholine substrate specificity of lecithin:cholesterol acyltransferase. 27224 - Excitation of indole-3-acetic acid (an auxin) in a linoleate-lipoxygenase system. |
Publication Detail:
|
Type: Journal Article; Research Support, Non-U.S. Gov't Date: 2006-05-19 |
Journal Detail:
|
Title: Molecular and cellular biochemistry Volume: 288 ISSN: 0300-8177 ISO Abbreviation: Mol. Cell. Biochem. Publication Date: 2006 Aug |
Date Detail:
|
Created Date: 2006-08-31 Completed Date: 2007-01-10 Revised Date: 2008-11-21 |
Medline Journal Info:
|
Nlm Unique ID: 0364456 Medline TA: Mol Cell Biochem Country: Netherlands |
Other Details:
|
Languages: eng Pagination: 201-12 Citation Subset: IM |
Affiliation:
|
Department of Human Health and Nutritional Sciences, University of Guelph, Guelph, Ontario, N1G 2W1, Canada. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
AMP-Activated Protein Kinases Aminoimidazole Carboxamide / analogs & derivatives, pharmacology Animals Antigens, CD36 / metabolism* Dose-Response Relationship, Drug Fatty Acid-Binding Proteins / metabolism* Fatty Acids / metabolism Hypoglycemic Agents / pharmacology Male Multienzyme Complexes / metabolism* Myocardium / enzymology, metabolism* Myocytes, Cardiac / drug effects, enzymology, metabolism* Oxidation-Reduction Protein-Serine-Threonine Kinases / metabolism* Rats Rats, Wistar Ribonucleotides / pharmacology Signal Transduction |
| Chemical | |
Reg. No./Substance:
|
0/Antigens, CD36; 0/FABPpm protein, rat; 0/Fatty Acid-Binding Proteins; 0/Fatty Acids; 0/Hypoglycemic Agents; 0/Multienzyme Complexes; 0/Ribonucleotides; 3031-94-5/AICA ribonucleotide; 360-97-4/Aminoimidazole Carboxamide; EC 2.7.11.1/AMP-Activated Protein Kinases; EC 2.7.11.1/Protein-Serine-Threonine Kinases |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Effects of various oxidants and antioxidants on the p38-MAPK signalling pathway in the perfused amph...
Next Document: Activity of lysosomal exoglycosidases in human gliomas.